{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:46:40Z","timestamp":1791056800365,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,11,16]],"date-time":"2013-11-16T00:00:00Z","timestamp":1384560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00277-013-1953-4","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T05:42:58Z","timestamp":1384494178000},"page":"761-767","source":"Crossref","is-referenced-by-count":15,"title":["Immune status of Fanconi anemia patients: decrease in T CD8 and CD56dim CD16+ NK lymphocytes"],"prefix":"10.1007","volume":"93","author":[{"given":"Gra\u00e7a A.","family":"Justo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Bitencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgana T. L.","family":"Castelo-Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Almeida-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilda Rachel","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian M.","family":"Rumjanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,16]]},"reference":[{"key":"1953_CR1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/35076590","volume":"2","author":"H Joenje","year":"2001","unstructured":"Joenje H, Patel KJ (2001) The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet 2:446\u2013457","journal-title":"Nat Rev Genet"},{"key":"1953_CR2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00062752-200301000-00011","volume":"10","author":"JRGC Bagby","year":"2003","unstructured":"Bagby JRGC (2003) Genetic basis of Fanconi anemia. Curr Opin Hematol 10:68\u201376","journal-title":"Curr Opin Hematol"},{"key":"1953_CR3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrc970","volume":"3","author":"AD D'Andrea","year":"2003","unstructured":"D'Andrea AD, Grompe M (2003) The Fanconi anaemia\/BRCA pathway. Nat Rev Cancer 3:23\u201334","journal-title":"Nat Rev Cancer"},{"key":"1953_CR4","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1101\/gad.1370505","volume":"19","author":"RD Kennedy","year":"2005","unstructured":"Kennedy RD, D'Andrea AD (2005) The Fanconi anemia\/BRCA pathway: new faces in the crowd. Genes Dev 19:2925\u20132940","journal-title":"Genes Dev"},{"issue":"4","key":"1953_CR5","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1182\/blood-2004-03-1094","volume":"104","author":"X Li","year":"2004","unstructured":"Li X, Yang Y, Yuan J, Hong P, Freie B, Orazi A, Haneline LS, Clapp DW (2004) Continuous in vivo infusion of interferon-gamma (IFN-\u03b3) preferentially reduces myeloid progenitor numbers and enhances engraftment of syngeneic wild-type cells in Fancc\u2212\/\u2212 mice. Blood 104(4):1204\u20131209","journal-title":"Blood"},{"issue":"12","key":"1953_CR6","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1182\/blood-2003-03-0971","volume":"102","author":"B Freie","year":"2003","unstructured":"Freie B, Li X, Ciccone SLM, Nawa K, Cooper S, Vogelweid C, Schantz L, Haneline LS, Orazi A, Broxmeyer HE, Lee S, Clapp DW (2003) Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis. Blood 102(12):4146\u20134152","journal-title":"Blood"},{"key":"1953_CR7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.33549\/physiolres.932115","volume":"60","author":"T Hucl","year":"2011","unstructured":"Hucl T, Gallmeier E (2011) DNA repair: exploiting the Fanconi anemia pathway as a potential therapeutic target. Physiol Res 60:453\u2013465","journal-title":"Physiol Res"},{"key":"1953_CR8","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.4049\/jimmunol.178.8.5277","volume":"178","author":"DP Sejas","year":"2007","unstructured":"Sejas DP, Rani R, Qiu Y, Zhang X, Fagerlie SR, Nakano H, Williams DA, Pang Q (2007) Inflammatory reactive oxygen species-mediated hemopoietic suppression in Fancc-deficient mice. J Immunol 178:5277\u20135287","journal-title":"J Immunol"},{"key":"1953_CR9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/BJ20082118","volume":"422","author":"A Ib\u00e1\u00f1ez","year":"2009","unstructured":"Ib\u00e1\u00f1ez A, R\u00edo P, Casado JA, Bueren JA, Fern\u00e1ndez-Luna JL, Pipa\u00f3n C (2009) Elevated levels of IL-1\u03b2 in Fanconi anaemia group A patients due to a constitutively active phosphoinositide 3-kinase-Akt pathway are capable of promoting tumour cell proliferation. Biochem J 422:161\u2013170","journal-title":"Biochem J"},{"issue":"1","key":"1953_CR10","first-page":"205","volume":"48","author":"P Hersey","year":"1982","unstructured":"Hersey P, Edwards A, Lewis R, Kemp A, Mcinnes J (1982) Deficient natural killer cell activity in a patient with Fanconi's anaemia and squamous cell carcinoma. Association with defect in interferon release. Clin Exp Immunol 48(1):205\u2013212","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"1953_CR11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1615\/CritRevImmunol.v26.i1.40","volume":"26","author":"SR Fagerlie","year":"2006","unstructured":"Fagerlie SR, Bagby GC (2006) Immune defects in Fanconi anemia. Crit Rev Immunol 26(1):81\u201396","journal-title":"Crit Rev Immunol"},{"key":"1953_CR12","first-page":"243","volume-title":"Aplastic anemia","author":"R Zaizov","year":"1978","unstructured":"Zaizov R, Matoth Y, Mamon Z (1978) Long term observations in children with Fanconi's anemia. In: Hibino S et al (eds) Aplastic anemia. University Park Press, Baltimore, p 243"},{"key":"1953_CR13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1651-2227.1977.tb07983.x","volume":"66","author":"FK Pederson","year":"1977","unstructured":"Pederson FK, Hertz H, Lundsteen C, Platz P, Thomsen M (1977) Indications of primary immune deficiency in Fanconi's anaemia. Acta Paediatr Scand 66:745","journal-title":"Acta Paediatr Scand"},{"key":"1953_CR14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2141.2011.08721.x","volume":"154","author":"KC Myers","year":"2011","unstructured":"Myers KC, Bleesing JJ, Davies SM, Zhang X, Martin LJ, Mueller R, Harris RE, Filipovich AH, Kovacic MB, Wells SI, Parinda A, Mehta PA (2011) Impaired immune function in children with Fanconi anaemia. Br J Haematol 154:234\u2013240","journal-title":"Br J Haematol"},{"issue":"6","key":"1953_CR15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.23435","volume":"88","author":"ET Korthof","year":"2013","unstructured":"Korthof ET, Svahn J, Peffault de Latour R et al (2013) Immunological profile of Fanconi anemia: a multicentric retrospective analysis of 61 patients. Am J Hematol 88(6):472\u2013476","journal-title":"Am J Hematol"},{"issue":"1","key":"1953_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/cmi.2009.3","volume":"6","author":"L Ch\u00e1vez-Gal\u00e1n","year":"2009","unstructured":"Ch\u00e1vez-Gal\u00e1n L, Arenas-Del Angel MC, Zenteno E, Ch\u00e1vez R, Lascurain R (2009) Cell death mechanisms induced by cytotoxic lymphocytes. Cel Mol Immunol 6(1):15\u201325","journal-title":"Cel Mol Immunol"},{"key":"1953_CR17","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/MOH.0b013e32833f10f1","volume":"17","author":"S Cooley","year":"2010","unstructured":"Cooley S, Weisdorf DS (2010) Natural killer cells and tumor control. Cur Opin Hematol 17:514\u2013521","journal-title":"Cur Opin Hematol"},{"key":"1953_CR18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/sj.leu.2403704","volume":"19","author":"O Penack","year":"2005","unstructured":"Penack O, Gentilini C, Fischer L, Asemissen AM, Scheibenbogen C, Thiel E, Uharek L (2005) CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets. Leukemia 19:835\u2013840","journal-title":"Leukemia"},{"key":"1953_CR19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.cdd.4402170","volume":"15","author":"A Moretta","year":"2008","unstructured":"Moretta A, Marcenaro E, Parolini S, Ferlazzo G, Moretta L (2008) NK cells at the interface between innate and adaptive immunity. Cell Death Diff 15:226\u2013233 (review)","journal-title":"Cell Death Diff"},{"key":"1953_CR20","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2010.08.031","volume":"142","author":"MT Orr","year":"2010","unstructured":"Orr MT, Lanier LL (2010) Natural killer cell education and tolerance. Cell 142:847\u2013856","journal-title":"Cell"},{"issue":"3","key":"1953_CR21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1023\/A:1015476114409","volume":"22","author":"R Tarazona","year":"2002","unstructured":"Tarazona R, Casado JG, Delarosa O et al (2002) Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals. J Clin Immunol 22(3):176\u2013183","journal-title":"J Clin Immunol"},{"issue":"12","key":"1953_CR22","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/QAD.0b013e32833b556f","volume":"24","author":"HS Hong","year":"2010","unstructured":"Hong HS, Eberhard JM, Keudel P et al (2010) Phenotypically and functionally distinct subsets contribute to the expansion of CD56\u2212\/CD16+ natural killer cells in HIV infection. AIDS 24(12):1823\u20131834","journal-title":"AIDS"},{"issue":"1","key":"1953_CR23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2567.2008.02887.x","volume":"126","author":"D Schepis","year":"2009","unstructured":"Schepis D, Gunnarsson I, Eloranta ML et al (2009) Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus. Immunology 126(1):140\u2013146","journal-title":"Immunology"},{"issue":"3","key":"1953_CR24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10072-007-0803-3","volume":"28","author":"M Saraste","year":"2007","unstructured":"Saraste M, Irjala H, Airas L (2007) Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta. Neurol Sci 28(3):121\u2013126","journal-title":"Neurol Sci"},{"issue":"4","key":"1953_CR25","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jmv.21742","volume":"82","author":"S Lee","year":"2010","unstructured":"Lee S, Watson MW, Flexman JP, Cheng W, Hammond T, Price P (2010) Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alpha and ribavirin therapy. J Med Virol 82(4):568\u2013574","journal-title":"J Med Virol"},{"key":"1953_CR26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1182\/blood.V73.2.391.391","volume":"73","author":"AD Auerbach","year":"1989","unstructured":"Auerbach AD, Rogatko A, Schroeder-Kurth TM (1989) International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood 73:391\u2013396","journal-title":"Blood"},{"issue":"11","key":"1953_CR27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","volume":"22","author":"MA Cooper","year":"2001","unstructured":"Cooper MA, Fehniger TA, Caligiuri MA (2001) The biology of human natural killer-cell subsets. Trends Immunol 22(11):633\u2013640","journal-title":"Trends Immunol"},{"key":"1953_CR28","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1600-0609.2005.00534.x","volume":"75","author":"GA Baruque","year":"2005","unstructured":"Baruque GA, Bitencourt MA, Pasquini R, Castelo-Branco MTL, Llerena JRJC, Rumjanek VM (2005) Apoptosis and expression of anti- and pro-apoptotic proteins in peripheral blood mononuclear cells of Fanconi anaemia patients: a study of 73 cases. Eur J Haematol 75:384\u2013390","journal-title":"Eur J Haematol"},{"issue":"1","key":"1953_CR29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000040861","volume":"100","author":"G Castello","year":"1998","unstructured":"Castello G, Gallo C, Napolitano M, Ascierto PA (1998) Immunological phenotype analysis of patients with Fanconi's anaemia and their family members. Acta Haematol 100(1):39\u201343","journal-title":"Acta Haematol"},{"key":"1953_CR30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","volume":"35","author":"N Zhang","year":"2011","unstructured":"Zhang N, Bevan MJ (2011) CD8+ T cells: foot soldiers of the immune system. Immunity 35:161\u2013168","journal-title":"Immunity"},{"key":"1953_CR31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2567.2011.03470.x","volume":"134","author":"M Strioga","year":"2011","unstructured":"Strioga M, Pasukoniene V, Characiejus D (2011) CD8+ CD28\u2212 and CD8+ CD57+ T cells and their role in health and disease. Immunology 134:17\u201332","journal-title":"Immunology"},{"key":"1953_CR32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.humimm.2011.01.009","volume":"72","author":"A Almeida-Oliveira","year":"2011","unstructured":"Almeida-Oliveira A, Smith-Carvalho M, Porto LC, Cardoso-Oliveira J, Ribeiro AS, Falc\u00e3o RR, Abdelhay E, Bouzas LF, Thuler LCS, Ornellas MH, Diamond HR (2011) Age-related changes in natural killer cell receptors from childhood through old age. H Immunol 72:319\u2013329","journal-title":"H Immunol"},{"issue":"2","key":"1953_CR33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0145-2126(87)90026-9","volume":"11","author":"P Froom","year":"1987","unstructured":"Froom P, Aghai E, Dobinsky JB, Quitt M, Lahat N (1987) Reduced natural killer activity in patients with Fanconi's anemia and in family members. Leuk Res 11(2):197\u2013199","journal-title":"Leuk Res"},{"issue":"5","key":"1953_CR34","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2133.1993.tb00497.x","volume":"129","author":"C Lebb\u00e9","year":"1993","unstructured":"Lebb\u00e9 C, Pinquier L, Rybojad M, Chomienne C, Ochonisky S, Miclea JM, Gluckman E, Morel P (1993) Fanconi's anaemia associated with multicentric Bowen's disease and decreased NK cytotoxicity. Br J Dermatol 129(5):615\u2013618","journal-title":"Br J Dermatol"},{"issue":"19","key":"1953_CR35","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1182\/blood-2010-09-303057","volume":"116","author":"L Moretta","year":"2010","unstructured":"Moretta L (2010) Dissecting CD56dim human NK cells. Blood 116(19):3689\u20133691","journal-title":"Blood"},{"key":"1953_CR36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4049\/jimmunol.179.1.89","volume":"179","author":"A Chan","year":"2007","unstructured":"Chan A, Hong DL, Atzberger A, Kollnberger S, Filer AD, Buckley CD, McMichael A, Enver T, Bowness P (2007) CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J Immunol 179:89\u201394","journal-title":"J Immunol"},{"key":"1953_CR37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4049\/jimmunol.172.1.88","volume":"172","author":"MJ Loza","year":"2004","unstructured":"Loza MJ, Perussia B (2004) The IL-12 signature: NK cell terminal CD56+high stage and effector functions. J Immunol 172:88\u201396","journal-title":"J Immunol"},{"key":"1953_CR38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2567.2007.02638.x","volume":"122","author":"CT Matos de","year":"2007","unstructured":"de Matos CT, Berg L, Micha\u00eblsson J, Fellander-Tsai L, K\u00e4rre K, S\u00f6derstr\u00f6m K (2007) Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94\/NKG2A in control of cytokine secretion. Immunology 122:291\u2013301","journal-title":"Immunology"},{"key":"1953_CR39","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2567.2007.02660.x","volume":"122","author":"JA Belisle","year":"2007","unstructured":"Belisle JA, Gubbels JA, Raphael CA et al (2007) Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125). Immunology 122:418\u2013429","journal-title":"Immunology"},{"key":"1953_CR40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1183\/09031936.05.00030805","volume":"26","author":"K Katchar","year":"2005","unstructured":"Katchar K, S\u00f6derstr\u00f6m K, Wahlstrom J, Eklund A, Grunewald J (2005) Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients. Eur Respir J 26:77\u201385","journal-title":"Eur Respir J"},{"key":"1953_CR41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1399-0039.2011.01714.x","volume":"78","author":"M Inngjerdingen","year":"2011","unstructured":"Inngjerdingen M, Kveberg L, Naper C, Vaage JT (2011) Natural killer cell subsets in man and rodents. Tissue Antigens 78:81\u201388","journal-title":"Tissue Antigens"},{"key":"1953_CR42","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-3083.2006.01883.x","volume":"65","author":"E Takahashi","year":"2007","unstructured":"Takahashi E, Kuranaga N, Satoh K, Habu Y, Shinomiya N, Asano T, Seki S, Hayakawa M (2007) Induction of CD16+CD56bright NK cells with antitumour cytotoxicity not only from CD16\u2212CD56bright NK cells but also from CD16\u2212CD56dim NK cells. Scand J Immunol 65:126\u2013138","journal-title":"Scand J Immunol"},{"key":"1953_CR43","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1182\/blood.V83.5.1216.1216","volume":"83","author":"F Rosselli","year":"1994","unstructured":"Rosselli F, Sanceau J, Gluckman E, Wietzerbin J, Moustacchi E (1994) Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia: II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor \u03b1. Blood 83:1216\u20131225","journal-title":"Blood"},{"key":"1953_CR44","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1182\/blood.V90.3.974","volume":"90","author":"RK Rathbun","year":"1997","unstructured":"Rathbun RK, Faulkner GR, Ostroski MH, Christianson TA, Hughes G, Jones G, Cahn R, Maziarz R, Royle G, Keeble W, Heinrich MC, Grompe M, Tower PA, Bagby GC (1997) Inactivation of the Fanconi anemia group C gene augments interferon-\u03b3-induced apoptotic response in hematopoietic cells. Blood 90:974\u2013985","journal-title":"Blood"},{"key":"1953_CR45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1590\/S0100-879X2009000300004","volume":"42","author":"DV Pilonetto","year":"2009","unstructured":"Pilonetto DV, Pereira NF, Bitencourt MA, Magdalena NIR, Vieira ER, Veiga LBA, Cavalli IJ, Ribeiro RC, Pasquini R (2009) FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia. Br J Med Biol Res 42:237\u2013243","journal-title":"Br J Med Biol Res"},{"key":"1953_CR46","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1182\/blood-2003-08-2915","volume":"103","author":"M Levitus","year":"2004","unstructured":"Levitus M, Rooimans MA, Steltenpool J, Cool NF, Oostra AB, Mathew CG et al (2004) Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes. Blood 103:2498\u20132503","journal-title":"Blood"},{"key":"1953_CR47","doi-asserted-by":"crossref","unstructured":"Shimamura A (2006) Inherited bone marrow failure syndromes: molecular features. Hematology Am Soc Hematol Educ Program 63\u201371","DOI":"10.1182\/asheducation-2006.1.63"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1953-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-013-1953-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1953-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T01:07:57Z","timestamp":1596848877000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-013-1953-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,16]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["1953"],"URL":"https:\/\/doi.org\/10.1007\/s00277-013-1953-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,16]]}}}